쎌바이오텍 반기보고서 (2016.06)
1. 요약재무정보

가. 요약연결재무정보

구 분	제 22기 2분기	제 21기	제 20기

(2016년6월말)	(2015년12월말)	(2014년12월말)

[유동자산]	61,142,231,560	54,150,513,012	38,800,498,113

·현금및현금성자산	12,265,680,491	7,272,875,829	5,385,808,119

·매출채권및기타유동채권	11,158,760,727	9,311,574,554	8,354,572,007

·금융상품자산	34,171,779,921	34,606,184,587	22,138,811,666

·단기투자자산	120,787,850	-	308,852,595

·재고자산	2,419,903,972	2,521,478,081	1,985,857,841

·기타유동자산	1,005,318,599	438,399,961	626,595,885

[비유동자산]	21,233,159,333	20,817,336,026	18,803,634,418

·장기매출채권및기타비유동채권	305,976,249	264,874,621	226,520,721

·금융상품자산	505,000,000	505,000,000	506,000,000

·장기투자증권	217,046,517	287,043,173	488,062,169

·유형자산	19,245,265,862	18,780,486,861	16,769,895,823

·무형자산	836,767,813	843,148,796	679,982,615

·이연법인세자산	123,102,892	136,782,575	133,173,090

자 산 총 계	82,375,390,893	74,967,849,038	57,604,132,531

[유동부채]	5,919,419,994	6,163,135,072	5,206,116,240

[비유동부채]	15,476,000	47,462,020	37,462,020

부 채 총 계	5,934,895,994	6,210,597,092	5,243,578,260

[지배기업 소유주지분]	76,440,494,899	68,757,251,946	52,360,554,271

[자본금]	4,700,000,000	4,700,000,000	4,700,000,000

[자본잉여금]	12,759,754,094	12,759,754,094	12,759,754,094

[자본조정]	(5,260,426,445)	(5,260,426,445)	(5,260,426,445)

[기타포괄손익누계액]	34,059,909	48,368,033	(1,189,378)

[이익잉여금]	64,207,107,341	56,509,556,264	40,162,416,000

[비지배지분]	-	-	-

자 본 총 계	76,440,494,899	68,757,251,946	52,360,554,271

기 간	(2016.01.01~	(2015.01.01~	(2014.01.01~

2016.06.30)	2015.12.31)	2014.12.31)

매출액	31,272,266,658	49,504,515,603	40,767,743,986

영업이익	12,961,025,000	18,758,807,947	12,905,528,179

당기순이익	10,785,551,077	17,505,140,264	10,402,695,484

지배기업 소유주지분	10,785,551,077	17,505,140,264	10,402,695,484

비지배지분	-	-	-

주당순이익	1,397	2,268	1,347

연결에포함된회사수	3	3	3

나.요약별도재무정보

구 분	제 22기 2분기	제 21기	제 20기

(2016년6월말)	(2015년12월말)	(2014년12월말)

[유동자산]	59,436,085,305	53,860,925,500	38,348,055,313

·현금및현금성자산	9,889,773,268	6,822,021,385	4,924,776,918

·매출채권및기타유동채권	12,866,191,803	10,418,352,866	9,337,826,816

·금융상품자산	33,271,779,921	33,706,184,587	21,238,811,666

·단기투자자산	120,787,850	-	308,852,595

·재고자산	2,404,083,728	2,488,101,480	1,936,220,896

·기타유동자산	883,468,735	426,265,182	601,566,422

[비유동자산]	23,766,768,174	22,233,829,427	20,442,417,308

·장기매출채권및기타비유동채권	37,850,411	8,850,411	8,850,411

·금융상품자산	505,000,000	505,000,000	506,000,000

·장기투자증권	135,576,723	224,009,929	461,164,833

·종속기업투자주식	3,218,445,020	2,118,819,740	2,065,845,531

·유형자산	19,098,955,052	18,616,137,994	16,701,018,122

·무형자산	700,976,615	689,416,428	644,222,381

·이연법인세자산	69,964,353	71,594,925	55,316,030

자 산 총 계	83,202,853,479	76,094,754,927	58,790,472,621

[유동부채]	5,172,431,353	5,415,695,302	4,263,932,125

[비유동부채]	20,476,000	47,677,600	37,677,600

부 채 총 계	5,192,907,353	5,463,372,902	4,301,609,725

[자본금]	4,700,000,000	4,700,000,000	4,700,000,000

[자본잉여금]	12,759,754,094	12,759,754,094	12,759,754,094

[자본조정]	(5,260,426,445)	(5,260,426,445)	(5,260,426,445)

[기타포괄손익누계액]	(1,089,072)	(3,298,882)	26,926,508

[이익잉여금]	65,811,707,549	58,435,353,258	42,262,608,739

자 본 총 계	78,009,946,126	70,631,382,025	54,488,862,896

종속ㆍ관계ㆍ공동기업 투자주식의 평가방법	원가법	원가법	원가법

기 간	(2016.01.01~	(2015.01.01~	(2014.01.01~

2016.06.30)	2015.12.31)	2014.12.31)

매출액	30,417,820,740	49,024,773,708	40,461,684,447

영업이익	12,554,336,259	19,214,527,103	14,616,719,951

당기순이익	10,464,354,291	17,330,744,519	12,034,346,815

주당순이익	1,355	2,245	1,559